A resting heart rate that has increased by 1 to 5 BPM from your pre-semaglutide baseline is expected and normal
The need of the hour is to have more randomized, double-blind, placebo-controlled trials with a larger sample size, long term follow-up period, with well defined primary and secondary outcomes, targeted to evaluate the efficacy and safety of the skin-lightening effects of topical, oral and parenteral glutathione
However, each Ozempic lawsuit is a separate case that will be addressed individually to reach a resolution that accounts for the plaintiffs unique damages
The AD/ADRD clinical trials pipeline currently includes tau-targeted ASOs that are in phase 1 and 2 clinical trials (Cummings et al., 2024)
We understand that weight loss can come with challenges such as plateaus or difficulty maintaining consistency
The KLOW blend is an advanced multi-peptide formulation combining TB-500 (Thymosin Beta-4 fragment), BPC-157, GHK-Cu, and KPV